Nearly 150 people have lost their lives due to an unknown and mysterious disease with flu-like symptoms in southwestern Congo in Africa. Th...

The bleeding eye virus or the Marburg disease has killed 15 people so far in Rwanda. This highly infectious pathogen is similar to the Ebol...

The US has advised citizens to reconsider travel to Rwanda due to a Marburg virus outbreak that has killed 12, mostly health workers, since...

Marburg virus disease poses a significant health threat due to its high fatality rate and rapid progression. Awareness of symptoms, prevent...

Two passengers traveling from Rwanda triggered a health scare at Hamburg Central Station amid fears they might be infected with the deadly ...

Marburg Virus Outbreak: Equatorial Guinea confirmed its first-ever outbreak of the Marburg virus on Monday after nine people whose samples ...

WHO Emergency Meeting: As of Monday, 9 people have succumbed to the Marburg virus and there are 16 other suspected cases. The virus which i...

In a press statement, WHO said that Equatorial Guinea confirmed its first-ever outbreak on Monday (local time) after the nine people's samp...

All the experts who spoke to AFP emphasised that for the next pandemic, regions such as Africa, South America, South Asia and the Middle Ea...

Disease X has been included to represent undiscovered infections that potentially trigger significant outbreaks worldwide. The specialists ...

The potential deal with the U.S. Department of Defense (DoD) would see Moderna's mRNA technology being used to develop a vaccine targeting ...

It was first reported in 1967 in a town called Marburg in Germany and in Belgrade, Yugoslavia (now Serbia).

Health officials said it was not immediately known whether the case was linked to an outbreak earlier this year in neighboring Guinea, whic...

Hyderabad-based Auro Vaccines and Pune’s Gennova Biopharmaceuticals are the latest to enter the fray, people in the know told.

The new antibodies identify and neutralise Marburg virus which has a mortality rate of up to 90 per cent.

Scientists from the NIAID have developed two experimental DNA vaccines that code for Ebola virus proteins from the Zaire and Sudan strains.